ACM
ANAC

Asymmetry Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Asymmetry Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,850
Closed -$473K – 23
2016
Q1 		$473K Sell
8,850
-6,741
-43% -$498K 1.23% 16
2015
Q4 		$1.76M Buy
15,591
+6,242
+67% +$688K 2.66% 16
2015
Q3 		$1.1M Buy
+9,349
New +$1.22M 2.45% 19

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Asymmetry Capital Management's ANAC Position: Q2 2016 in Review

Asymmetry Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 8,850 shares — an estimated $473K sold.

Asymmetry Capital Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $1.76M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Asymmetry Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Asymmetry Capital Management sold 8,850 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $473K.
  • Asymmetry Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
  • Asymmetry Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $1.76M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Asymmetry Capital Management's 13F filing for Q2 2016, filed 5 Aug 2016.